Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R T Prehn

Showing results (61-70 of 72) with videos related to

Pageof 8
Sort By:
Annals of Internal Medicine|March 1, 1972
Immunotherapy: the need for critical studiesR S Bornstein, J W Yarbro, R T Prehn
Journal of the National Cancer Institute|August 1, 1976
Invasion and metastasis of a xenogeneic tumor in nude miceH Maguire, H C Outzen, R P Custer, et al.
Journal of the National Cancer Institute|August 1, 1973
Does the absence of immunologic surveillance affect the tumor incidence in "nude" mice? First recorded spontaneous lymphoma in a "nude" mouseR P Custer, H C Outzen, G J Eaton, et al.
Journal of the Reticuloendothelial Society|January 1, 1975
Spontaneous and induced tumor incidence in germfree "nude" miceH C Outzen, R P Custer, G J Eaton, et al.
European Journal of Cancer|February 1, 1979
Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patientsJ Berkelhammer, M J Mastrangelo, R E Bellet, et al.
International Journal of Cancer|October 15, 1975
Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donorsJ Berkelhammer, M J Mastrangelo, J F Laucius, et al.
European Journal of Cancer|July 1, 1978
Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapyJ Berkelhammer, M J Mastrangelo, R E Bellet, et al.
Journal of the National Cancer Institute|November 1, 1972
Attempted induction of tumor antigens in carcinogen-treated cellsH C Outzen, E J Andrews, M A Basombrío, et al.
Cancer Research|January 1, 1975
Clinical and immunological significance of human melanoma cytotoxic antibodyA J Bodurtha, D O Chee, J F Laucius, et al.
Cancer|February 1, 1976
Intralesional BCG in the treatment of metastatic malignant melanomaM J Mastrangelo, H L Sulit, L M Prehn, et al.
Pageof 8

Showing results (61-70 of 72) with videos related to

Sort By:
Pageof 8
Annals of Internal Medicine|March 1, 1972
Immunotherapy: the need for critical studiesR S Bornstein, J W Yarbro, R T Prehn
Journal of the National Cancer Institute|August 1, 1976
Invasion and metastasis of a xenogeneic tumor in nude miceH Maguire, H C Outzen, R P Custer, et al.
Journal of the National Cancer Institute|August 1, 1973
Does the absence of immunologic surveillance affect the tumor incidence in "nude" mice? First recorded spontaneous lymphoma in a "nude" mouseR P Custer, H C Outzen, G J Eaton, et al.
Journal of the Reticuloendothelial Society|January 1, 1975
Spontaneous and induced tumor incidence in germfree "nude" miceH C Outzen, R P Custer, G J Eaton, et al.
European Journal of Cancer|February 1, 1979
Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patientsJ Berkelhammer, M J Mastrangelo, R E Bellet, et al.
International Journal of Cancer|October 15, 1975
Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donorsJ Berkelhammer, M J Mastrangelo, J F Laucius, et al.
European Journal of Cancer|July 1, 1978
Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapyJ Berkelhammer, M J Mastrangelo, R E Bellet, et al.
Journal of the National Cancer Institute|November 1, 1972
Attempted induction of tumor antigens in carcinogen-treated cellsH C Outzen, E J Andrews, M A Basombrío, et al.
Cancer Research|January 1, 1975
Clinical and immunological significance of human melanoma cytotoxic antibodyA J Bodurtha, D O Chee, J F Laucius, et al.
Cancer|February 1, 1976
Intralesional BCG in the treatment of metastatic malignant melanomaM J Mastrangelo, H L Sulit, L M Prehn, et al.
Pageof 8